Celsus Therapeutics PLC (ADR) Stock Nasdaq
Equities
US15119A2024
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.64M |
---|---|---|---|---|---|
Net income 2022 | -17M | Net income 2023 | -10M | EV / Sales 2022 | - |
Net cash position 2022 | 13.25M | Net cash position 2023 | 3.84M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.65
x | P/E ratio 2023 |
-1.53
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.78% |
Latest transcript on Celsus Therapeutics PLC (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |